OAM
Optimal Asset Management Portfolio holdings
AUM
$793M
1-Year Est. Return
28.14%
This Fund
S&P 500
1 Year Est. Return
+28.14%
AUM
$793M
AUM Growth
-$51.6M
(-6.1%)
Holding
356
Top Buys
| 1 | +$2.13M | |
| 2 | +$846K | |
| 3 | +$753K | |
| 4 |
Organon & Co
OGN
|
+$215K |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$101K |
Top Sells
| 1 | +$8.09M | |
| 2 | +$7.23M | |
| 3 | +$6.6M | |
| 4 |
Liberty Broadband Class C
LBRDK
|
+$4.49M |
| 5 |
Warner Bros
WBD
|
+$3.58M |
Sector Composition
| 1 | Technology | 24.12% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 11.98% |
| 4 | Consumer Staples | 11.55% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
351
Liberty Broadband Class C
LBRDK
$7.71B
| – | – |
-25,858
|
|
||
352
Target
TGT
$52.3B
| – | – |
-29,896
|
|
||
353
Vanguard Intermediate-Term Treasury ETF
VGIT
$36.4B
| – | – |
-5,050
|
|
||
|
354
Warner Bros
WBD
$67.8B
| – | – |
-116,588
|
|
||
|
MXIM
355
DELISTED
Maxim Integrated Products
MXIM
| – | – |
-8,000
|
|
||
|
ALXN
356
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-16,706
|
|